Thus, EPR targeted KS90 could be used to deplete tumor MGMT and selectively sensitize tumor cells to the more cytotoxic O6-(2-chloroethyl)guanine assault, thus resulting in synergistic tumor cell kill (Figure 2). This evidence concerns the gene MGMT and neoplasm.